Filing Details
- Accession Number:
- 0000899243-19-019337
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-08 21:26:00
- Reporting Period:
- 2019-07-03
- Accepted Time:
- 2019-07-08 21:26:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1731831 | Eidos Therapeutics Inc. | EIDX | Pharmaceutical Preparations (2834) | 463733671 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1743881 | Bridgebio Pharma, Inc. | C/O Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2550 San Francisco CA 94104 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-03 | 882,353 | $29.90 | 24,575,501 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- The shares were purchased by BridgeBio Pharma, LLC, a wholly-owned subsidiary of the Reporting Person.
Billionaire Hedge Funds
